Compare PHAR & GDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | GDOT |
|---|---|---|
| Founded | 1988 | 1999 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 885.7M | 724.4M |
| IPO Year | 2020 | 2010 |
| Metric | PHAR | GDOT |
|---|---|---|
| Price | $13.77 | $13.39 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 3 | 2 |
| Target Price | ★ $38.33 | $11.00 |
| AVG Volume (30 Days) | 4.8K | ★ 544.8K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $2,080,491,000.00 |
| Revenue This Year | $10.04 | $11.07 |
| Revenue Next Year | $2.51 | $5.69 |
| P/E Ratio | $3,041.22 | ★ $40.45 |
| Revenue Growth | N/A | ★ 20.69 |
| 52 Week Low | $9.54 | $9.31 |
| 52 Week High | $21.34 | $15.41 |
| Indicator | PHAR | GDOT |
|---|---|---|
| Relative Strength Index (RSI) | 57.84 | 59.23 |
| Support Level | $12.98 | $12.75 |
| Resistance Level | $17.60 | $13.73 |
| Average True Range (ATR) | 0.38 | 0.25 |
| MACD | 0.19 | 0.03 |
| Stochastic Oscillator | 86.30 | 63.64 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for todays workforce.